Home - The Dermatology Digest

Advertisement

Advertisement

U.S. FDA Approves Starjemza, a New Stelara Biosimilar

May 27, 2025

U.S. FDA Grants Interchangeability Designation to Samsung Bioepis and Organon’s Humira Biosimilar

May 27, 2025

AI Medical Technology’s Dermalyser Earns CE Mark in Europe

May 27, 2025

Landmark WHA Resolution Recognizes Skin Diseases as a Global Public Health Priority

May 26, 2025

New Nanoencapsulated CBD Cream Protects Against UVA-Induced Skin Damage

May 23, 2025

Celltrion’s Humira Biosimilar Receives U.S. FDA Interchangeability Designation for all Its Approved Dosages and Strengths

May 23, 2025

Advertisement

Advertisement

Let’s Talk About Acne

New and Emerging Therapies in Dermatology

Advertisement

Latest Issue

Latest Supplements

Advertisement

Digital Edition Archive